logo-loader
viewRathbone Brothers PLC

Rathbones' risk and return strategy has paid off for multi-asset funds during crisis

David Coombs, head of multi-asset investing at Rathbones (LON:RAT) explains how his risk and return strategy has thrown up some unlikely winners during the coronavirus crisis. The portfolio was strong in healthcare ahead of the pandemic, he says, with stakes in med-tech group Abbot and pharma giant Roche, both of which have been very active in the fight against COVID-19. Another good performer has been Clorox, which prior to the pandemic had been a solid producer of cleaning wipes, he says, but has now seen its markets take off. “We are pragmatic in how we invest,” he told Proactive. “Currencies, commodities, bonds and equities, we go where we think the best returns are”.

Quick facts: Rathbone Brothers PLC

Price: 1680 GBX

LSE:RAT
Market: LSE
Market Cap: £963.95 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Britvic PLC sees acceleration in at-home channel sales lead by Pepsi-MAX in...

Britvic PLC (OTCQX:BTVCF) (LON:BVIC) Director of Investor Relations Stephen Nightingale tells Proactive the manufacturer of soft drinks saw an increase at-home channel sales with its slew of trusted soft drinks, despite a months-wide lockdown in the UK. Nightingale says its carbonates...

9 hours, 7 minutes ago

2 min read